ImmunityBio, Inc. IBRX Finance Lease, Principal Payments
Finance Lease, Principal Payments at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s finance lease, principal payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ImmunityBio, Inc.'s finance lease, principal payments?
- ImmunityBio, Inc. (IBRX) reported finance lease, principal payments of $13K in Q1 2026.
- What is the long-term trend for ImmunityBio, Inc.'s finance lease, principal payments?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s finance lease, principal payments has grown at a -21.6% compound annual growth rate (CAGR), from $58K to $28K.